Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

We were honoured to host a celebration marking this year’s Nobel Prize in Physiology or Medicine, awarded to our alumnus Sir Peter Ratcliffe.

Sir Peter Ratcliffe gives a speech as part of his Nobel Prize celebration at the MRC WIMM

“How is it that I came to be in this rather fortunate position” were the opening words by Sir Peter Ratcliffe, winner of this year’s Nobel Prize in Physiology or Medicine. The speech was part of a celebration hosted at the MRC WIMM on Monday the 21st of October, the anniversary of Alfred Nobel’s birth.

Attended by over 300 people, the party was an opportunity to celebrate Sir Peter Ratcliffe’s achievements, not only scientific but also his efforts to support and foster the scientific and medical community in Oxford. Sir John Bell, Regius Professor of Medicine at the University of Oxford, thanked Sir Peter for his contributions over the years to the Medical School, the MRC WIMM and the Nuffield Department of Medicine, and lauded him as a “real clinician scientist”. These sentiments were echoed by Prof Richard Cornall, Head of the Nuffield Department of Medicine, a position previously occupied by Sir Peter.


Nobel Prize party© Julie Stevens


Prof. Doug Higgs presents Sir Peter Ratcliffe with a (chocolate) Nobel Prize© Julie StevensProf. Doug Higgs presents Sir Peter Ratcliffe with a (chocolate) Nobel PrizeOur Director Prof Doug Higgs summarised the main contributions by the Ratcliffe group to the understanding of oxygen sensing and regulation, and recalled the early days of the research at the MRC WIMM. Sir Peter first established his research group in our institute in 1989, but his initial plan had been to become a consultant nephrologist. After an ill-fated trip to Wales led him to turn down a position as a consultant physician in Cardiff, our institute’s founder, the late Sir David Weatherall, suggested that he applied for a grant from the Wellcome Trust. Sir Peter acknowledged the importance of the continued support by the Trust in the last 30 years, as well as the many friends and colleagues who contributed to his research over the years.

Vital to this exchange of ideas was the MRC WIMM coffee room. Sir Peter fondly recalled the time spent in its “perfect” armchairs- “ it was in those armchairs that we discussed endlessly what we might do to solve this oxygen sensing problem”. He recalled the contribution of all of those who brought new techniques to the institute, and hence contributed technically or intellectually to the work. The coffee room has always been a vital feature of our institute, and something that our founder Sir David Weatherall, fought hard to maintain under space pressures to make more lab space available. Sir David was fondly remembered at the event, and this Nobel prize is a symbol of his legacy fostering an environment where basic, curiosity-driven science could lead to breakthroughs in clinical medicine. “I wish David was here, he would have been enormously proud” said Prof Doug Higgs

“It was here that it was all hatched”- said Sir Peter Ractliffe- “ and it is a really great pleasure to be here again”


Dr Bruno Holthof (CEO of Oxford University Hospitals NHS Foundation Trust), Prof. Doug Higgs (Director of the MRC WIMM), Sir Peter Ratcliffe, Prof. Richard Cornall (Head of NDM), Sir John Bell (Regius Chair of Medicine) and Dame Kay Davies (Professor of Anatomy)© Julie StevensDr Bruno Holthof (CEO of Oxford University Hospitals NHS Foundation Trust), Prof. Doug Higgs (Director of the MRC WIMM), Sir Peter Ratcliffe, Prof. Richard Cornall (Head of NDM), Sir John Bell (Regius Chair of Medicine) and Dame Kay Davies (Professor of Anatomy)

Similar stories

Strong cytotoxic T cell responses to an internal viral component are associated with mild COVID-19 disease

Study from the Dong Group reveals key differences in the adaptive immune responses of patients with mild vs. severe COVID-19, highlighting a potential new vaccine target.

$2m awarded to explore the role of ancestry in vaccine response

The Lymph nodE single-cell Genomics AnCestrY (LEGACY) Network will create an ethnically diverse single-cell atlas of the response to commonly used vaccines such as flu vaccines with a focus on responses in lymph nodes.

Study uncovers how low blood iron diminishes immune response

The Drakesmith group finds that low blood serum iron levels can inhibit T-cell and B-cell immune responses to vaccines and infections.

Interferon-b trial shows positive results

A trial of a new inhaled antiviral drug for COVID-19 has shown positive results and the drug is now moving into a larger international phase 3 trial of hospitalised patients. MRC HIU's Professor Ling-Pei Ho is one of the main co-authors on the paper.